Suppr超能文献

细胞融合在癌症中的机制。

Mechanisms of Cell Fusion in Cancer.

机构信息

Department of Biology, Jackson State University, Jackson, MS, USA.

Research Centers in Minority Institutions (RCMI), Center for Health Disparity Research (RCMI-CHDR), Jackson State University, Jackson, MS, USA.

出版信息

Results Probl Cell Differ. 2024;71:407-432. doi: 10.1007/978-3-031-37936-9_19.

Abstract

Cell-cell fusion is a normal physiological mechanism that requires a well-orchestrated regulation of intracellular and extracellular factors. Dysregulation of this process could lead to diseases such as osteoporosis, malformation of muscles, difficulties in pregnancy, and cancer. Extensive literature demonstrates that fusion occurs between cancer cells and other cell types to potentially promote cancer progression and metastasis. However, the mechanisms governing this process in cancer initiation, promotion, and progression are less well-studied. Fusogens involved in normal physiological processes such as syncytins and associated factors such as phosphatidylserine and annexins have been observed to be critical in cancer cell fusion as well. Some of the extracellular factors associated with cancer cell fusion include chronic inflammation and inflammatory cytokines, hypoxia, and viral infection. The interaction between these extracellular factors and cell's intrinsic factors potentially modulates actin dynamics to drive the fusion of cancer cells. In this review, we have discussed the different mechanisms that have been identified or postulated to drive cancer cell fusion.

摘要

细胞融合是一种正常的生理机制,需要细胞内和细胞外因素的协调调控。该过程的失调可能导致骨质疏松症、肌肉畸形、妊娠困难和癌症等疾病。大量文献表明,癌细胞与其他细胞类型之间发生融合,可能促进癌症的进展和转移。然而,在癌症的起始、促进和进展过程中,控制这一过程的机制研究得还不够充分。在正常生理过程中起作用的融合蛋白,如合胞体蛋白和相关因子,如磷脂酰丝氨酸和膜联蛋白,也被观察到在癌细胞融合中起关键作用。一些与癌细胞融合相关的细胞外因子包括慢性炎症和炎症细胞因子、缺氧和病毒感染。这些细胞外因子与细胞内在因子之间的相互作用可能调节肌动蛋白动力学,从而驱动癌细胞的融合。在这篇综述中,我们讨论了已经确定或假设的不同机制来驱动癌细胞融合。

相似文献

1
Mechanisms of Cell Fusion in Cancer.
Results Probl Cell Differ. 2024;71:407-432. doi: 10.1007/978-3-031-37936-9_19.
2
Functions of the fusogenic and non-fusogenic activities of Syncytin-1 in human physiological and pathological processes.
Biochem Biophys Res Commun. 2025 May 1;761:151746. doi: 10.1016/j.bbrc.2025.151746. Epub 2025 Apr 2.
3
Cell-Cell Fusion Mediated by Viruses and HERV-Derived Fusogens in Cancer Initiation and Progression.
Cancers (Basel). 2021 Oct 26;13(21):5363. doi: 10.3390/cancers13215363.
4
Cell fusions in mammals.
Histochem Cell Biol. 2008 May;129(5):551-61. doi: 10.1007/s00418-008-0411-1. Epub 2008 Mar 20.
5
Intrinsic signalling factors associated with cancer cell-cell fusion.
Cell Commun Signal. 2023 Apr 4;21(1):68. doi: 10.1186/s12964-023-01085-5.
7
Cell Fusion and Syncytia Formation in Cancer.
Results Probl Cell Differ. 2024;71:433-465. doi: 10.1007/978-3-031-37936-9_20.
9
Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins.
J Biol Chem. 2019 Dec 27;294(52):19844-19851. doi: 10.1074/jbc.AC119.010611. Epub 2019 Nov 17.
10
Virus and cell fusion mechanisms.
Annu Rev Cell Dev Biol. 2014;30:111-39. doi: 10.1146/annurev-cellbio-101512-122422. Epub 2014 Jun 27.

本文引用的文献

1
Extracellular Events Involved in Cancer Cell-Cell Fusion.
Int J Mol Sci. 2022 Dec 16;23(24):16071. doi: 10.3390/ijms232416071.
2
Polyploid giant cancer cells and cancer progression.
Front Cell Dev Biol. 2022 Oct 5;10:1017588. doi: 10.3389/fcell.2022.1017588. eCollection 2022.
3
Linking unfolded protein response to ovarian cancer cell fusion.
BMC Cancer. 2022 Jun 7;22(1):622. doi: 10.1186/s12885-022-09648-4.
4
Cell-Cell Fusion Mediated by Viruses and HERV-Derived Fusogens in Cancer Initiation and Progression.
Cancers (Basel). 2021 Oct 26;13(21):5363. doi: 10.3390/cancers13215363.
5
Hybrid Formation and Fusion of Cancer Cells In Vitro and In Vivo.
Cancers (Basel). 2021 Sep 6;13(17):4496. doi: 10.3390/cancers13174496.
7
A melanoma patient with macrophage-cancer cell hybrids in the primary tumor, a lymph node metastasis and a brain metastasis.
Cancer Genet. 2021 Aug;256-257:162-164. doi: 10.1016/j.cancergen.2021.05.009. Epub 2021 May 28.
8
Spontaneous Fusion of MSC with Breast Cancer Cells Can Generate Tumor Dormancy.
Int J Mol Sci. 2021 May 31;22(11):5930. doi: 10.3390/ijms22115930.
9
Ancient Adversary - HERV-K (HML-2) in Cancer.
Front Oncol. 2021 May 13;11:658489. doi: 10.3389/fonc.2021.658489. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验